Aims-To investigate adenovirus pulmonary infections in bone marrow transplant (BMT) recipients. Methods-Formalin fixed, paraffin wax embedded lung tissue was examined from 13 necropsy cases after BMT using PCR and in situ hybridisation to detect adenovirus DNA. The ElA region of the adenoviral genome was targeted for PCR. In situ hybridisation was performed only in the PCR positive cases. Results-Of the 13 lung specimens analysed, nine cases were negative for adenoviral nucleic acid. Four (30%) PCR and two (15%) in situ hybridisation positive cases were found. In some of the patients there were clinical and pathological indications that some diseases might be associated with adenovirus infection-haemorrhagic cystitis (three cases); necrotising pneumonia (one case). In necrotising pneumonia in which no pathogenic agents had been shown by conventional histological study, the in situ hybridisation technique showed positive staining for adenovirus. In a patient who died of renal failure caused by adenovirus nephritis, both PCR and in situ hybridisation were positive in the lung as 
adenovirus DNA. The ElA region of the adenoviral genome was targeted for PCR. In situ hybridisation was performed only in the PCR positive cases. Results-Of the 13 lung specimens analysed, nine cases were negative for adenoviral nucleic acid. Four (30%) PCR and two (15%) in situ hybridisation positive cases were found. In some of the patients there were clinical and pathological indications that some diseases might be associated with adenovirus infection-haemorrhagic cystitis (three cases); necrotising pneumonia (one case). In necrotising pneumonia in which no pathogenic agents had been shown by conventional histological study, the in situ hybridisation technique showed positive staining for adenovirus. In a patient who died of renal failure caused by adenovirus nephritis, both PCR and in situ hybridisation were positive in the lung as and 20 ,ug/ml of salmon sperm DNA. The radiolabelled probe was added to the filter and hybridised at 650C. The filter was washed twice at room temperature for 10 minutes in 2 x SSC,0 1% SDS; then at 65°C for 30 minutes in 0-1 x SSC, 0-1% SDS. The filter was then subjected to autoradiography. The 
In situ hybridisation analysis was performed only for the PCR positive cases. Four PCR positive lung and one kidney (from case 10) samples were examined. For each sample, two identical sections were put on a slide coated with poly-L-lysine. One side was hybridised with adenovirus DNA probe using the ENZO PathoGene DNA probe assay for the identification of adenovirus (ENZO Diagnostics, New York, USA), the other side served as a control and was hybridised with biotinylated pBR 322 DNA. In situ hybridisation was performed according to the manufacturer's instructions. The presence of hybridised probe was determined by the reaction of hydrogen peroxide and 3-amino-9-ethylcarbazole.
Cultured Hep-II cells infected with adenovirus types 2 and 5 served as the positive control. They were fixed with' formalin and embedded in paraffin wax.
Results
The PCR product was subjected to Southern blotting after electrophoresis, and probed with radiolabelled DNA from the corresponding region of the adenovirus genome. The expected size of the amplified products was 675 base pairs. The autoradiograph result of PCR for the ElA region is shown in fig 1. The DNA extracted from cases 1, 9, 10, and 11 (30%) was positive for the ElA region by PCR, as were the positive controls (table 2) . The positive controls consisted of 5 ng of adenovirus type 2 genomic DNA and the extracted DNA from paraffin wax sections of Graham 293 cells, and the kidney sample with adenovirus inclusion bodies. The negative control "no template DNA" did not show bands either in the gel or the autoradiograph. Figure 2A shows that the cultured cells infected with adenovirus type 5 positively stained for adenovirus with in situ hybridisation as well as the cultured cells infected with adenovirus type 2. Among the four PCR positive cases, two (cases 10 and 11) (15%) immunosuppressive treatment, organ transplantation, or chemotherapy are increasing in number, as are those with AIDS. In such patients viral pulmonary infections have become one of the most important causes of death. However, viral infection in the lung is difficult to distinguish from other interstitial pulmonary disorders, such as drug toxicity, neoplasia, pulmonary haemorrhage, allergic reactions, and pulmonary oedema. 19 Besides, it is difficult to determine which species of virus is responsible for the lesion with or without viral inclusion bodies.
The incidence of adenovirus infections after BMT has been based on the clinical isolation of the virus, the prevalent serotypes being adenovirus types 1, 2, 5, 7, 11, 34, and 35.10 However, the isolation rate is not an indicator of the morbidity. To diagnose invasive infections, samples of the diseased organs for culture and histological examination are needed; and these should not be highly specific and sensitive.
Polymerase chain reaction (PCR) and in situ hybridisation for detecting viral nucleic acid have been established for the diagnosis of several viral infections. However, the sensitivity of PCR is extremely high, and positive PCR results merely indicate the presence of the viral genome, and not necessarily that the virus is related to the present disease. In this study the ElA region of the adenoviral genome was targeted by the PCR method. The ElA gene can sensitise cells to destruction by cytokines20 and it could have an essential role in adenovirus infection through activation of other adenoviral genomic DNA. 21 The sensitivity of in situ hybridisation for the detection of adenoviral genome has been reported before.'6 A detection limit of five to 10 copies of adenoviral DNA using in situ hybridisation has been estimated, and adenovirus was demonstrated by in situ hybridisation only in acute cases of adenovirus pneumonia. '6 We examined adenovirus infections in necropsy lung specimens from 13 necropsy patients after BMT using PCR and in situ hybridisation techniques, because adenovirus pneumonia is one of the most common causes of mortality in transplant recipients. Some of our cases had some pathological evidence suggestive of adenovirus infection: necrotising pneumonia (n = 1); colitis (n = 1); hepatitis (n = 1); and haemorrhagic cystitis (n = 3) (table 2) . In this study organs other than the lungs were not examined.
In our cases the clinical isolation rate of adenovirus was 15% and the incidence of adenovirus detection by PCR was 30% in the patients who died after BMT ( (cases 1 and 10), one patient with necrotising pneumonia (case 11), and one without any clinical and pathological findings related to adenovirus (case 9). Because PCR is highly sensitive for the detection of a viral genome, the positive PCR results do not necessarily indicate active viral infection. Therefore, the in situ hybridisation study was performed in these PCR positive cases.
Of the four positive PCR cases, two were also positive on in situ hybridisation. The lung section from the patient with necrotising pneumonia stained positively on in situ hybridisation. The PCR and in situ hybridisation findings, taken together with the clinical and histological data, indicate that the necrotising pneumonia was caused by adenovirus. However, the in situ hybridisation positive cells were scattered throughout the lesions. This is probably because the lesion was necrotic and the normal lung structure had been destroyed. As a result, the number of infected but viable and well preserved epithelial cells had decreased.
After the in situ hybridisation method had disclosed adenovirus in the lung tissue, we reexamined haematoxylin and eosin stained sections and were able to point out cells with viral inclusion bodies in the lung tissue of the case with necrotising pneumonia (case 11) ( fig 2D) . Definite diagnosis of active adenovirus infection can be established, if histological findings correlate with positive staining on in situ hybridisation.
In conclusion, our results raise the possibility that in addition to conventional histological and virological investigations, the combination of PCR and in situ hybridisation might be useful for detecting and diagnosing adenovirus infections in patients undergoing BMT. Further study with larger numbers of subjects is needed to evaluate the sensitivity and clinical value of these techniques. 
